Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Mon, 14th Sep 2020 13:13

Cambridge Cognition Holdings PLC - Cambridge, England-based neuroscience technology - Appoints Diurnal Group PLC Chief Financial Officer Richard Bungay as non-executive director, effective immediately. Bungay joined Diurnal at the start of 2017, moving from Mereo BioPharma Group PLC, where he had been CFO and chief operation officer. Previously, he had been CFO of Verona Pharma PLC.

Current stock price: 40.10 pence

Year-to-date change: up 43%

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 May 2015 15:19

Earnings, Trading Statements Calendar - Week Ahead

Read more
8 May 2015 05:19

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 May 2015 15:01

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 May 2015 05:14

Earnings, Trading Statements Calendar - Week Ahead

Read more
6 May 2015 14:59

Earnings, Trading Statements Calendar - Week Ahead

Read more
6 May 2015 05:14

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 May 2015 15:15

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Mar 2015 12:00

LONDON MIDDAY BRIEFING: RBS Kicks Off Further Stake Sale In Citizens

Read more
23 Mar 2015 11:22

UK WINNERS & LOSERS: Broker Ratings Changes Drive FTSE 100 Movers

Read more
23 Mar 2015 08:18

Verona Pharma Sees "Very Encouraging" Interim Results In RPL554 Trial

Read more
3 Mar 2015 12:20

UK MIDDAY BRIEFING: Barclays Profit Again Hit By Provisions

Read more
3 Mar 2015 11:33

UK WINNERS & LOSERS: Barclays Provisions Disappoint Market

Read more
3 Mar 2015 08:46

Verona Pharma To Post Less Than Expected Loss But Warns On 2015 Costs

Read more
16 Feb 2015 09:36

DIRECTOR DEALINGS: Verona Pharma CEO Buys 1 Million Shares

Read more
14 Jan 2015 15:05

Verona Pharma chairman increases stake

The chairman of Verona Pharma increased his stake in the company following Monday's news that the biotechnology firm has dosed its first group of volunteers in its asthma trial. David Ebsworth showed confidence in the future of the business by purchasing 803,107 shares for 1.35p each, spending a tot

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.